Krystal Biotech, Inc.
Nasdaq KRYS · Pittsburgh, PA
Works in Dermatology · Genetic & rare · GI & liver · Neurology · Ophthalmology · Respiratory
Krystal Biotech, Inc. is a clinical trial sponsor based in Pittsburgh, PA, listed as Nasdaq KRYS. It has 11 active clinical trials with 802 planned participants, across 6 therapeutic areas. Since 2021 it has completed 3 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq KRYS
Pipeline · 11 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Krystal Biotech, Inc
Krystal Biotech, Inc is lead sponsor of 11 active clinical trials on ClinicalTrials.gov, with 802 planned participants, in Dermatology, Genetic & rare, GI & liver, Neurology and other areas. Since 2021 it has completed 3 trials and stopped 2 early.
Krystal Biotech, Inc is based in Pittsburgh, PA and is listed as Nasdaq KRYS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Krystal Biotech, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-21.
Approve Suite is not affiliated with Krystal Biotech, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.